Navigation Links
Lexi-Comp Integrates Martindale: The Complete Drug Reference into Lexi-Comp ONLINE™
Date:4/14/2009

Clinicians treating diverse patient populations can access domestic and international pharmacology information in one reliable resource

Hudson, OH (PRWEB) April 14, 2009 -- Lexi-Comp, Inc., a provider of clinical reference information for healthcare professionals, has partnered with RPS Publishing to deliver the highly-regarded international pharmacology data found in Martindale: The Complete Drug Reference within Lexi-Comp® ONLINE™, Lexi-Comp's web-based application for hospitals and health-systems. At the European Association of Hospital Pharmacists Congress in March, the pharmacopoeia of drugs and medicines from around the world was officially made available as an additional database in Lexi-Comp ONLINE. The partnership provides medical professionals treating diverse patient populations with one robust resource that includes domestic and international drug information.

Martindale covers medications from over 40 countries and regions. The database contains over 6,500 drug monographs, 181,000 proprietary preparations, 48,000 references, and 19,000 manufacturers' details. Monographs include Chemical Abstracts Service (CAS) and Anatomical Therapeutic Chemical Classification System (ATC) numbers to help readers refer to other information systems. Other fields of information include Physical Characteristics, Cyrillic Names, Adverse Effects, Precautions, Interactions, Uses, and Administration.

Robert Bolick, Managing Director of RPS Publishing, comments, "We are pleased to be partnering with Lexi-Comp. This agreement forms part of our drive to expand the glob
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. EBSCO Publishing and Lexi-Comp Formalize Product Partnership to Enable Seamless Integration Between Products
2. Lexi-Comp Databases Now Available for the iPhone™ and iPod touch
3. Lexi-Comp Point-of-Care Information Now Available on Smartphones, Coming Soon for the iPhone™
4. Lexi-Comp, Inc. Offers Diagnosis and Disease Management Tool
5. Allscripts Integrates Electronic Health Record With Innovative Patient Kiosk
6. Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk
7. Secure EDI Integrates VeriFone IPCharge in Real Time Patient Payment and Claims Processing Solutions Suite
8. Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives!
9. Vasculitis Foundation Integrates Education, Outreach and Technology in First-Ever Webinar on Potentially Life-Threatening Disease
10. Genomatix integrates genome-wide open chromatin from next generation sequencing
11. Professional Products, Inc. Integrates Clinical Skills and Simulation Center at the Johns Hopkins Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 1U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 2U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 3U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 4U S Food and Drug Administration Clears Vermillions OVA1 28TM 29 Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 56963 5West to Present at Two Upcoming Investor Conferences 56960 1West to Present at Two Upcoming Investor Conferences 56960 2Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 1Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults 56959 2